Welcome to Current Immunology, Today is
Latest advances in targeted biologic therapy for myasthenia gravis: from complement inhibition to FcRn antagonism
LI Xue, SHI Jina, LIU Yanjun, LIU Wei
Current Immunology . 2026, (4): 555 -560 .